Anoopkumar-Dukie S et al. |
Mitochondrial modulation of oxygen-dependent radiosensitivity in some human tumour cell lines. |
2009 |
Br J Radiol |
pmid:19366737
|
Ahn KJ et al. |
Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. |
2003 |
Br J Radiol |
pmid:14711782
|
Murphy GJ et al. |
Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. |
2003 |
Br J Surg |
pmid:12808614
|
Middleton SJ et al. |
Adult small intestinal transplantation in England and Wales. |
2003 |
Br J Surg |
pmid:12808622
|
Morris-Stiff GJ et al. |
Sequential changes in plasma selenium concentration after cadaveric renal transplantation. |
2004 |
Br J Surg |
pmid:14991636
|
Wilson CH et al. |
Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants. |
2005 |
Br J Surg |
pmid:15856479
|
Waller JR et al. |
Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia. |
2002 |
Br J Surg |
pmid:12390379
|
Brook NR et al. |
Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. |
2003 |
Br J Surg |
pmid:12905557
|
Jain S et al. |
Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. |
2000 |
Br J Surg |
pmid:11091246
|
Bicknell GR et al. |
Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. |
2000 |
Br J Surg |
pmid:11091247
|
White DJ |
Immunosuppression for heart transplantation. |
1993 |
Br. J. Biomed. Sci. |
pmid:7694717
|
Reichert TE et al. |
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. |
1999 |
Br. J. Cancer |
pmid:10555752
|
Andersson Y et al. |
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. |
2009 |
Br. J. Cancer |
pmid:19773757
|
Patel NP et al. |
Treatment of eosinophilic pustulosis of infancy with topical tacrolimus. |
2012 |
Br. J. Dermatol. |
pmid:22563626
|
Reich K et al. |
Topical tacrolimus for pyoderma gangrenosum. |
1998 |
Br. J. Dermatol. |
pmid:9892935
|
Kyllönen H et al. |
Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. |
2004 |
Br. J. Dermatol. |
pmid:15214906
|
Meingassner JG et al. |
Pimecrolimus does not affect Langerhans cells in murine epidermis. |
2003 |
Br. J. Dermatol. |
pmid:14616380
|
Wilsmann-Theis D et al. |
Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. |
2004 |
Br. J. Dermatol. |
pmid:15214910
|
Danby SG and Cork MJ |
The effects of pimecrolimus on the innate immune response in atopic dermatitis. |
2013 |
Br. J. Dermatol. |
pmid:23362967
|
Lerbaek A and Agner T |
Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15214914
|
Edmonds EV et al. |
Nodular prurigo responding to topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15214918
|
Murrell DF et al. |
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. |
2007 |
Br. J. Dermatol. |
pmid:17935515
|
Schmitt J et al. |
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. |
2011 |
Br. J. Dermatol. |
pmid:20819086
|
Liao YH et al. |
Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. |
2007 |
Br. J. Dermatol. |
pmid:17935517
|
Schauber J et al. |
Topical treatment of perianal eczema with tacrolimus 0.1%. |
2009 |
Br. J. Dermatol. |
pmid:19575757
|
Rustin MH |
The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. |
2007 |
Br. J. Dermatol. |
pmid:17854353
|
Bunker CB |
Male genital lichen sclerosus and tacrolimus. |
2007 |
Br. J. Dermatol. |
pmid:17854373
|
Wu CS et al. |
FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. |
2012 |
Br. J. Dermatol. |
pmid:22540338
|
Tennis P et al. |
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. |
2011 |
Br. J. Dermatol. |
pmid:21466537
|
Afshar M et al. |
The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study. |
2013 |
Br. J. Dermatol. |
pmid:22577776
|
Remitz A et al. |
Tacrolimus ointment improves psoriasis in a microplaque assay. |
1999 |
Br. J. Dermatol. |
pmid:10417522
|
Vidal D and Alomar A |
Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:14996128
|
Lan CC et al. |
FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts: new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun-exposed skin. |
2011 |
Br. J. Dermatol. |
pmid:21039414
|
Carroll CL et al. |
Better medication adherence results in greater improvement in severity of psoriasis. |
2004 |
Br. J. Dermatol. |
pmid:15491434
|
Wenzel J et al. |
Successful treatment of recalcitrant Wegener's granulomatosis of the skin with tacrolimus (Prograf). |
2004 |
Br. J. Dermatol. |
pmid:15491443
|
Chung BY et al. |
The proactive treatment of atopic dermatitis with tacrolimus ointment in Korean patients: a comparative study between once-weekly and thrice-weekly applications. |
2013 |
Br. J. Dermatol. |
pmid:23110605
|
Kabashima K et al. |
Treatment of eosinophilic pustular folliculitis (Ofuji's disease) with tacrolimus ointment. |
2004 |
Br. J. Dermatol. |
pmid:15491457
|
Aguilar-Bernier M et al. |
Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis. |
2005 |
Br. J. Dermatol. |
pmid:15840123
|
Higgins E and Collins P |
Recurrent bullous erythema multiforme treated with topical tacrolimus 0·1% ointment. |
2011 |
Br. J. Dermatol. |
pmid:21114481
|
Pitt M et al. |
A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. |
2006 |
Br. J. Dermatol. |
pmid:16704646
|
Vente C et al. |
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233234
|
Lyon CC et al. |
Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233300
|
Jolles S et al. |
Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. |
1999 |
Br. J. Dermatol. |
pmid:10233301
|
Walker SL et al. |
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. |
2002 |
Br. J. Dermatol. |
pmid:12174136
|
Simon D et al. |
Successful treatment of pityriasis lichenoides with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15149526
|
Mrowietz U et al. |
The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. |
1998 |
Br. J. Dermatol. |
pmid:9990361
|
Jain S and Stephens CJ |
Successful treatment of disseminated granuloma annulare with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15149532
|
Anstey A |
Therapeutic advances and shift in disease paradigm for atopic dermatitis. |
2008 |
Br. J. Dermatol. |
pmid:19036027
|
Ghislain PD et al. |
Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. |
2004 |
Br. J. Dermatol. |
pmid:15149540
|
Katoh N et al. |
Cutaneous sarcoidosis successfully treated with topical tacrolimus. |
2002 |
Br. J. Dermatol. |
pmid:12100200
|
McElwee KJ et al. |
Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. |
1997 |
Br. J. Dermatol. |
pmid:9390322
|
Hoeger PH et al. |
The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. |
2009 |
Br. J. Dermatol. |
pmid:19067708
|
Lan CC et al. |
FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. |
2004 |
Br. J. Dermatol. |
pmid:15377358
|
Piram M et al. |
Short- and long-term outcome of linear morphoea in children. |
2013 |
Br. J. Dermatol. |
pmid:24032480
|
Chuh AA |
The application of topical tacrolimus in vesicular pemphigoid. |
2004 |
Br. J. Dermatol. |
pmid:15030368
|
Gollnick H et al. |
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. |
2008 |
Br. J. Dermatol. |
pmid:18341665
|
Erdogan M et al. |
Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. |
2002 |
Br. J. Dermatol. |
pmid:12072063
|
Hjelmgren J et al. |
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data. |
2007 |
Br. J. Dermatol. |
pmid:17263826
|
Volz T et al. |
Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study. |
2008 |
Br. J. Dermatol. |
pmid:18647310
|
Nissi R et al. |
Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment. |
2009 |
Br. J. Dermatol. |
pmid:19659469
|
Lan CC et al. |
FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. |
2005 |
Br. J. Dermatol. |
pmid:16120133
|
Alomar A et al. |
The role of topical calcineurin inhibitors in atopic dermatitis. |
2004 |
Br. J. Dermatol. |
pmid:15548171
|
Ständer S et al. |
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. |
2007 |
Br. J. Dermatol. |
pmid:17388925
|
Barbier N et al. |
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. |
2004 |
Br. J. Dermatol. |
pmid:14746622
|
Rubegni P et al. |
A case of reticular erythematous mucinosis treated with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:14746650
|
Rigopoulos D et al. |
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. |
2009 |
Br. J. Dermatol. |
pmid:19120329
|
Oranje AP et al. |
Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis. |
2009 |
Br. J. Dermatol. |
pmid:18795918
|
Wataya-Kaneda M et al. |
A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity. |
2011 |
Br. J. Dermatol. |
pmid:21692771
|
Spergel JM et al. |
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. |
2007 |
Br. J. Dermatol. |
pmid:17573885
|
Abe R et al. |
Severe refractory chronic actinic dermatitis successfully treated with tacrolimus ointment. |
2002 |
Br. J. Dermatol. |
pmid:12452891
|
Taher ZA et al. |
Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. |
2009 |
Br. J. Dermatol. |
pmid:19438859
|
Lonsdale-Eccles AA and Velangi S |
Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. |
2005 |
Br. J. Dermatol. |
pmid:16086755
|
Undre NA et al. |
Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. |
2009 |
Br. J. Dermatol. |
pmid:19076975
|
Caproni M et al. |
The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. |
2007 |
Br. J. Dermatol. |
pmid:17223872
|
Bilenchi R et al. |
Human papillomavirus reactivation following topical tacrolimus therapy of anogenital lichen sclerosus. |
2007 |
Br. J. Dermatol. |
pmid:17223903
|
Mashiko M et al. |
A case of angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment. |
2006 |
Br. J. Dermatol. |
pmid:16536847
|
Böhm M et al. |
Resolution of lichen aureus in a 10-year-old child after topical pimecrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15327576
|
Fiorentino DF et al. |
The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes. |
2011 |
Br. J. Dermatol. |
pmid:21166661
|
Brouard MC et al. |
Erosive pustular dermatosis of the leg: report of three cases. |
2002 |
Br. J. Dermatol. |
pmid:12366427
|
Lewis FM and Neill SM |
Safety of calcineurin inhibitors in the management of lichen sclerosis. |
2007 |
Br. J. Dermatol. |
pmid:17535239
|
Connolly M and Kennedy C |
Exfoliative cheilitis successfully treated with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15270904
|
Hengge UR et al. |
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. |
2006 |
Br. J. Dermatol. |
pmid:17034535
|
Kang HY and Choi YM |
FK506 increases pigmentation and migration of human melanocytes. |
2006 |
Br. J. Dermatol. |
pmid:17034537
|
Clayton TH et al. |
Topical tacrolimus for facial psoriasis. |
2003 |
Br. J. Dermatol. |
pmid:12932257
|
Lübbe J and Sorg O |
Tacrolimus ointment and skin carcinogenesis in the DMBA/TPA model in mice. |
2004 |
Br. J. Dermatol. |
pmid:15606530
|
Burkhart CG and Burkhart CN |
Tacrolimus and topical steroids: which is more effective? |
2004 |
Br. J. Dermatol. |
pmid:15606537
|
Tzung TY et al. |
Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. |
2007 |
Br. J. Dermatol. |
pmid:17199600
|
Lee DH et al. |
Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. |
2008 |
Br. J. Dermatol. |
pmid:18363758
|
Moreno-Arias GA et al. |
Plasma cell balanitis treated with tacrolimus 0.1%. |
2005 |
Br. J. Dermatol. |
pmid:16307659
|
Lonowski S et al. |
Vitiligo: a potential autoimmune sequela of DRESS syndrome. |
2016 |
Br. J. Dermatol. |
pmid:27038429
|
Bos JD |
Topical tacrolimus and pimecrolimus are not associated with skin atrophy. |
2002 |
Br. J. Dermatol. |
pmid:11903264
|
Wolff K et al. |
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. |
2005 |
Br. J. Dermatol. |
pmid:15948996
|
Rigopoulos D et al. |
Pimecrolimus 1% cream in the treatment of disseminated granuloma annulare. |
2005 |
Br. J. Dermatol. |
pmid:15949015
|
Feldmann KA et al. |
Is topical tacrolimus effective in alopecia areata universalis? |
2002 |
Br. J. Dermatol. |
pmid:12410729
|
Pereira U et al. |
Mechanisms of the sensory effects of tacrolimus on the skin. |
2010 |
Br. J. Dermatol. |
pmid:20302583
|
Grassberger M et al. |
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. |
1999 |
Br. J. Dermatol. |
pmid:10468798
|
Ho N et al. |
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. |
2011 |
Br. J. Dermatol. |
pmid:21457214
|
Weissenbacher S et al. |
Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. |
2007 |
Br. J. Dermatol. |
pmid:17493072
|
Williams HC |
Preventing eczema flares with topical corticosteroids or tacrolimus: which is best? |
2011 |
Br. J. Dermatol. |
pmid:21271989
|
Takeuchi S et al. |
Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey. |
2015 |
Br. J. Dermatol. |
pmid:25421804
|